These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9125650)

  • 1. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
    Bécheur H; Dall'osto H; Chatellier G; Charton-Bain MC; Aubertin JM; Attar A; Bloch F; Petite JP
    Dig Dis Sci; 1997 Apr; 42(4):789-91. PubMed ID: 9125650
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid for intrahepatic cholestasis of pregnancy: good for the mother, not bad for the baby.
    Carey EJ; White P
    Evid Based Med; 2013 Dec; 18(6):e55. PubMed ID: 23635844
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
    Jain P
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Marschall HU
    Scand J Gastroenterol; 2016; 51(2):256. PubMed ID: 26315148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intrahepatic cholestasis of pregnancy. New treatment].
    Ranek L; Ott P
    Ugeskr Laeger; 1999 Sep; 161(39):5411-2. PubMed ID: 10553352
    [No Abstract]   [Full Text] [Related]  

  • 7. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
    Trauner M; Graziadei IW
    Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. URSO in obstetric cholestasis: not a bear market.
    Elias E
    Gut; 1999 Sep; 45(3):331-2. PubMed ID: 10446097
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrahepatic Cholestasis Owing to a Novel Heterozygous ABCG8 Mutation and SLC4A2 Polymorphism With Favorable Outcome Under Ursodeoxycholic Acid.
    Ciocan D; Voican CS; Barbu V; Corpechot C; Rainteau D; Prevot S; Lebrun A; Perlemuter G
    Am J Gastroenterol; 2019 Sep; 114(9):1556-1559. PubMed ID: 31335361
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
    Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
    Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.
    Alenezi B; Lamoureux E; Alpert L; Szilagyi A
    Dig Dis Sci; 2005 Jan; 50(1):196-200. PubMed ID: 15712660
    [No Abstract]   [Full Text] [Related]  

  • 13. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].
    Mörk H; al-Taie O; Klinge O; Scheurlen M
    Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is ursodeoxycholic acid effective for intrahepatic cholestasis of pregnancy?
    Sepúlveda Marín S; Contreras Maragaño V; Vera C
    Medwave; 2016 Jan; 16 Suppl 1():e6361. PubMed ID: 26817509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy?
    Chappell LC; Chambers J; Thornton JG; Williamson C
    BMJ; 2018 Feb; 360():k104. PubMed ID: 29419378
    [No Abstract]   [Full Text] [Related]  

  • 16. Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans.
    Duttala S; Tobi M; Dingell JD
    Gastroenterology; 2006 Feb; 130(2):619-20; author reply 620. PubMed ID: 16472623
    [No Abstract]   [Full Text] [Related]  

  • 17. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases.
    Berkane N; Cocheton JJ; Brehier D; Merviel P; Wolf C; Lefèvre G; Uzan S
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):941-6. PubMed ID: 11081677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy.
    Laifer SA; Stiller RJ; Siddiqui DS; Dunston-Boone G; Whetham JC
    J Matern Fetal Med; 2001 Apr; 10(2):131-5. PubMed ID: 11392594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity.
    Lykavieris P; Bernard O; Jacquemin E
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101472. PubMed ID: 32565202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.